OverviewSuggest Edit
QIAGEN N.V., through its subsidiaries, provides technologies and products for preanalytical sample preparation and linked molecular assay solutions. The company also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. Technologies Sample Technologies: The company’s sample technologies provide access to the content of biological samples. These include solutions for the collection, stabilization, purification, handling and storage of any analyte (deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and protein) from any sample (blood, bone, and tissue).
| Type | Public | |
| Founded | 1984 | |
| HQ | Hilden, DE | Map |
| Website | qiagen.com | |
| Employee Ratings | More | |
| Overall Culture | A+ | More |
Key People/Management at Qiagen
Thierry Bernard
Chief Executive Officer
Stéphane Bancel
Supervisory Director
Dominic O'Neil
Associate Director DNA Product Development
Stephany Foster
Senior Vice President, Head of Human Resources
Metin Colpan
Supervisory Director
Barthold Piening
Senior Vice President, Head of Global Operations
Qiagen Office Locations
Qiagen has offices in Hilden, Bodman-Ludwigshafen, Germantown, Holmesglen and in 19 other locations
Hilden, DE (HQ)
1 Qiagen Str.
Bodman-Ludwigshafen, DE
Bodenseeallee 20
Antwerpen, BE
Quellinstraat 49
Toronto, CA
4400-181 Bay St
Shenzhen Shi, CN
4 Kewen Rd, Nanshan Qu
København, DK
Fruebjergvej 3
Qiagen Financials and Metrics
Qiagen Revenue
Market capitalization (12-Nov-2020) | 9.1b |
Closing stock price (12-Nov-2020) | 40.3 |
Qiagen's current market capitalization is €9.1 b.
Qiagen Cybersecurity Score
Qiagen Environment, Social & Governance (ESG) Ratings
Qiagen Online and Social Media Presence
15.09k Twitter followers
Qiagen has 15.09k Twitter Followers. The number of followers has increased 0.3% month over month and increased 1.5% quarter over quarter
Qiagen's Trends
Twitter Engagement Stats for @QIAGEN
3.8k
Tweets
824
Following
15.1k
Followers
43
Tweets last 30 days
2
Avg. likes per Tweet
81.4%
Tweets with engagement
Qiagen Company Culture
Overall Culture
A+
85/100
CEO Rating
C+
70/100
Compensation
A-
79/100
Qiagen News and Updates
November 11, 2020
: Qiagen stock rises on announced COVID-19 test
Qiagen NV QGEN shares rose in the extended session Wednesday after the Netherlands-based medical diagnostics company said it will begin selling a portable COVID-19 test in the United States. Qiagen shares rose 4% after hours, following a 0.9% rise in the regular session to close at $46.51. Called t…
September 08, 2020
Qiagen to launch rapid coronavirus test it says could be used in airports and stadiums
Qiagen CEO Thierry Bernard said the antigen tests are meant to supplement, not replace, the molecular, or PCR, tests, the most accurate tests on the market.
August 13, 2020
Press release from Davidson Kempner regarding Qiagen
LONDON, Aug. 13, 2020 /PRNewswire/ -- Davidson Kempner is pleased that the majority of investors have rejected the wholly inadequate offer made by Thermo Fisher Scientific. The low acceptance level of 47.02% is a clear signal that there is widespread confidence in the long-term prospects...
August 13, 2020
Press release from Davidson Kempner regarding Qiagen
LONDON, Aug. 13, 2020 /PRNewswire/ -- Davidson Kempner is pleased that the majority of investors have rejected the wholly inadequate offer made by Thermo Fisher Scientific. The low acceptance level of 47.02% is a clear signal that there is widespread confidence in the long-term prospects...
July 31, 2020
Davidson Kempner Letter to Qiagen NV
LONDON, July 31, 2020 /PRNewswire/ -- To: Dr. Håkan Björklund (Chairman of the Supervisory Board) Stéphane Bancel (Supervisory Board Director) Dr. Metin Colpan (Supervisory Board Director) Prof. Dr. Ross Levine (Supervisory Board Director) Prof. Dr. Elaine Mardis (Supervisory Board...
July 18, 2020
Thermo Fisher May Need to Boost Qiagen Bid Again, Investor Says
Thermo Fisher May Need to Boost Qiagen Bid Again, Investor Says
Qiagen Blogs
November 11, 2020
New eBook! Interpreting NGS Tests for Inherited Disorders: 3 trends that will change everything
Today genetic innovation is advancing at breakneck pace. Since the first whole genome was sequenced in 2003, a feat that...
The post New eBook! Interpreting NGS Tests for Inherited Disorders: 3 trends that will change everything appeared first on Bioinformatics Software and Services | QIAGEN Digital…
November 02, 2020
New Features and Functionalities of QCI Interpret
We are excited to announce the general availability of the Fall 2020 Release of QIAGEN Clinical Insight (QCI) Interpret. This...
The post New Features and Functionalities of QCI Interpret appeared first on Bioinformatics Software and Services | QIAGEN Digital Insights.
October 30, 2020
New! QCI Interpret Translational for Human Exome Sequencing
Introducing QCI Interpret Translational, a new software solution for NGS variant assessment Whole-exome sequencing (WES) using next-generation sequencing (NGS) technology...
The post New! QCI Interpret Translational for Human Exome Sequencing appeared first on Bioinformatics Software and Services | …
October 29, 2020
Publication Roundup: QIAGEN CLC Genomics Workbench
Recently, there have been many noteworthy papers citing QIAGEN CLC Genomics Workbench, a comprehensive, easy-to-use toolbox that ensures continuity in...
The post Publication Roundup: QIAGEN CLC Genomics Workbench appeared first on Bioinformatics Software and Services | QIAGEN Digital Insights.
October 26, 2020
Discover a specialized collection of viral ‘omics data to help advance your viral research
Are you a scientist or public health lab professional studying viral host response? Do you find it challenging to find...
The post Discover a specialized collection of viral ‘omics data to help advance your viral research appeared first on Bioinformatics Software and Services | QIAGEN Digital Insigh…
October 26, 2020
Highlights of the latest update to QIAGEN CLC Microbial Genomics Module 20.1
Using viral reference databases for phylogeny construction and taxonomic profiling of samples with low viral load This blog tutorial highlights...
The post Highlights of the latest update to QIAGEN CLC Microbial Genomics Module 20.1 appeared first on Bioinformatics Software and Services | QIAGEN Dig…
Qiagen Frequently Asked Questions
When was Qiagen founded?
Qiagen was founded in 1984.
Who are Qiagen key executives?
Qiagen's key executives are Thierry Bernard, Stéphane Bancel and Dominic O'Neil.
How many employees does Qiagen have?
Qiagen has 5,300 employees.
Who are Qiagen competitors?
Competitors of Qiagen include Integrated DNA Technologies, VWR and Access Biologicals.
Where is Qiagen headquarters?
Qiagen headquarters is located at 1 Qiagen Str., Hilden.
Where are Qiagen offices?
Qiagen has offices in Hilden, Bodman-Ludwigshafen, Germantown, Holmesglen and in 19 other locations.
How many offices does Qiagen have?
Qiagen has 27 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies